| Literature DB >> 28316605 |
Tinne Boeckx1, Ana Winters1, K Judith Webb1, Alison H Kingston-Smith1.
Abstract
Polyphenol oxidases (PPOs) have a recognized role during pathogen and arthropod attack. As an immediate consequence of such wounding, cellular compartmentation is destroyed allowing the chloroplastic PPO enzyme to interact with vacuolar substrates catalyzing the oxidation of monophenols and/or o-diphenols to o-diquinones. This ultimately results in a reduction in the nutritional value of wounded tissue through the formation of non-digestible secondary melanin pigments. However, the chloroplastic location of PPO enzyme could indicate a role for PPO in undamaged tissues. In this study, a wild-type red clover population exhibiting high leaf PPO activity had significantly higher yield than a low leaf PPO mutant population while leaf isoflavonoids and hydroxycinnammates (PPO substrates) accumulated at similar levels in these plants. These data suggest that the presence of leaf PPO activity affects plant vigor. Understanding how this advantage is conferred requires knowledge of the cellular mechanism, including intra-organellar substrates. Here we present evidence of candidate PPO substrates within chloroplasts of wild-type red clover, including the monophenolic acid, coumaroyl malate, and low levels of the diphenolic acid, phaselic acid (caffeoyl malate). Interestingly, chloroplastic phaselic acid concentration increased significantly under certain growth conditions. We discuss the implications of this in regard to a potential role for chloroplastic PPO in undamaged leaves.Entities:
Keywords: PPO; chloroplast; coumaroyl hexoside; coumaroyl malate; flavonoids; hydroxycinnamic acids; polyphenol oxidase
Year: 2017 PMID: 28316605 PMCID: PMC5334603 DOI: 10.3389/fpls.2017.00237
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Figure 1Growth rate and yield of wild-type and low leaf PPO mutant red clover over 8 weeks. (A) Growth rate showing plant height (cm), and (B) yield of leaf, stem, and total leaf and stem combined (g dry matter). Wild-type (WT) solid; low leaf PPO mutant (MUT) dashed; data show average data with error bars ± SEM (n = 15); (A) p < 0.001; (B) nsd.
Seed germination and size of wild-type and low PPO mutant red clover.
| Wild-type Mutant | 75 ± 4.88 | 7.87 ± 0.71 | 16.60 ± 1.46 |
| 60 ± 7.64 | 4.53 ± 0.56 | 9.07 ± 1.13 | |
Average seed germination (%), number of shoots per plant, and number of leaves per shoot after 3 weeks growth. Error bars ± SEM (n = 60).
Leaf PPO activity established wild-type and mutant plants grown in glasshouse.
| Wild-type Mutant | 137.2 ± 56.78 | 381.8 ± 77.15 | 518.9 ± 109.02 |
| 4.9 ± 2.92 | 11.8 ± 2.74 | 16.7 ± 5.52 | |
Average active, latent, and total leaf PPO activity after 3 weeks growth. Error bars ± SEM (n = 5).
Figure 2Soluble phenol content in leaves of wild-type and low PPO mutant red clover after 8 weeks. Wild-type (WT) solid; low leaf PPO mutant (MUT) dashed line, (A) isoflavonoids: formononetin (Form), biochanin A (Bio A) and total isoflavonoid content (Tot Iso) and (B) hydroxycinnamic acids: (HCA) feruloyl malate (Fer mal), coumaroyl malate (Coum mal), coumaroyl Dopa (Coum Dopa), phaselic acid (Phas), clovamide (Clov), total hydroxycinnamates (Total HCAs). Error bars ± SEM (n = 15); (A,B) nsd.
Figure 3Structures of the isoflavonoid conjugates identified in red clover leaf extracts. Positioning of the glycone groups were adapted from Lin et al. (2000) and were not confirmed in this study.
Figure 4Structures of tentatively identified hydroxcinnamic acid conjugates and likely PPO substrate candidates found in red clover leaf extracts. The positioning of the hydroxyl, glycoside and amino acid groups was based on Parveen et al. (2010).
Figure 5Representative HPLC/UV chromatograms (240–400 nm) of the phenolics in representative purified (A) whole leaf extracts and b) chloroplasts of red clover. Final concentration of the extracts shown was 0.1 μg total chlorophyll (Chla + Chlb) μL−1 extract of which 10 μL was injected. Panel (B) has an enlarged insert to show smaller peaks more clearly. Table 4 shows detail of identified peaks 1–28: 1, caffeic acid; 2, 2-hydroxy-2,3-dihydrogenistein hexoside; 3, caffeoyl malate (phaselic acid); 4, unidentified compound; 5, caffeoyl DOPA (clovamide); 6, coumaroyl malate; 7, coumaroyl DOPA; 7a caffeoyl tyrosine; 8, feruloyl DOPA; 9, caffeoyl mevalonate (tentative); 10, coumaroyl tyrosine; 11, quercetin hexoside; 12, quercetin hexoside malonate; 13, formononetin hexoside, formic acid adduct; 14, kaempferol hexoside; 15, kaempferol hexoside malonate; 16, formononetin hexoside, sodium formate adduct; 17, irilone hexoside, formic adduct; 18, irilone conjugate formic adduct; 19, biochanin A hexoside, formic adduct; 20, formononetin hexoside malonate; 21, isomer of peak (19), formic acid adduct; 22, pratensein; 23, formononetin hexoside succinate; 24, biochanin A, hexoside malonate; 25, pseudobaptigenin; 26, formononetin; 27, biochanin A conjugate; 28, biochanin A.
Proportion of red clover isoflavonoids and hydroxycinnamic acid conjugates, present in whole leaves and chloroplasts compiled from separate comparative chromatograms.
| Chloroplasts | 26 | Formononetin | 25.0 | Flavonoid synthesized in chloroplasts |
| Coumaroyl hexoside | 20.0 | Potential leaf PPO substrate | ||
| 28 | Biochanin A | 14.3 | Flavonoid synthesized in chloroplasts | |
| 17 | Irilone hexoside | 5.88 | Flavonoid synthesized in chloroplasts | |
| 19 | Biochanin A hexoside | 3.45 | Flavonoid synthesized in chloroplasts | |
| 13 | Formononetin hexoside | 1.89 | Flavonoid synthesized in chloroplasts | |
| 2 | 2-hydroxy-2,3-dihydrogenistein hexoside | 0.31 | Flavonoid synthesized in chloroplasts | |
| 6 | Coumaroyl malate | 0.15 | Potential PPO monophenol substrate | |
| External to chloroplasts | 1 | Caffeic acid | 0.01 | |
| 10 | Coumaroyl tyrosine | 0.01 | Potential leaf PPO substrates | |
| 3 | Caffeoyl malate (phaselic acid) | 0.002 | Main leaf PPO substrates | |
| 5 | Caffeoyl 3,4-dihydroxyphenylalanine DOPA (clovamide) | 0.0004 | Main leaf PPO substrates | |
| 7a | Caffeoyl tyrosine | n/d | Potential leaf PPO substrates | |
| 8 | Feruloyl DOPA | n/d | Potential leaf PPO substrates | |
| 9 | Caffeoyl mevalonate | n/d | Potential leaf PPO substrates |
Illuminated, young fully expanded leaves from wild-type red clover (T. pratense cv. Milvus; n = 3) were sampled for chloroplast and whole leaf extracts. Molecular weight (MW) was detected by mass spectrometry in −ve ion mode. Peak areas were collected from full MS spectra and normalized per μg total leaf chlorophyll (Chl.
Tandem MS fragmentation (MS.
| 1 | 12.5 | 179(−) | 328, 280sh | Caffeic acid | ||
| 2 | 13.5 | 449(−) | 283 | 2-hydroxy-2,3-dihydrogenistein hexoside | ||
| 3 | 16.2/17.2 | 295(−) | 328, 301sh | Caffeoyl malate (phaselic acid) | ||
| 4 | 17.7 | 435 | 275 | Unidentified compound | ||
| 5 | 19.6 | 358(−) | 290, 321 | Caffeoyl DOPA (clovamide) | ||
| 6 | 20.9/21.5 | 279(−) | 313 | Coumaroyl malate | ||
| 7 | 23.1/23.9 | 342(−) | N.D | Coumaroyl DOPA* | ||
| 8 | 24.7 | 372(−) | 293sh, 325 | Feruloyl DOPA | ||
| 9 | 25.4/26.2/ | 309(−) | 302sh, 328 | Caffeoyl mevalonate (tentative) | ||
| 10 | 26.9 | 326(−) | N.D. | Coumaroyl tyrosine | ||
| 11 | 29.4 | 463 | 301, 179,151, 343 | Quercetin hexoside | ||
| 12 | 30.8 | 549(−) 505(−), frag. | 505 | (301) | N.D. | Quercetin hexoside malonate |
| 13 | 32.6 | 475(−) | 248, 296sh | Formononetin hexoside, formic acid adduct | ||
| 14 | 33.4 | 447(−) 285(−), frag. | N.D. | Kaempferol hexoside3 | ||
| 15 | 35.4 | 533 | ND | Kaempferol hexoside malonate3 | ||
| 16 | 35.8 | 515(−) 267(−), frag. | 258, 297 | Formononetin hexoside, sodium formate adduct | ||
| 17 | 36.1 | 505(−) | (459) | N.D. | Irilone hexoside, formic adduct3 | |
| 18 | 37.7 | 547(−) | 297 | N.D. | Irilone conjugate formic adduct | |
| 19 | 39.0 | 491(−) | 268 | 260, 326sh | Biochanin A hexoside, formic adduct | |
| 20 | 40.3 | 517(+) | 249, 296sh | Formononetin hexoside malonate | ||
| 21 | 41.5 | 491(−) | N.D. | Isomer of peak ( | ||
| 22 | 42.6 | 299(−) | Pratensein | |||
| 23 | 43.8 | 531(+) | 260, 296sh | Formononetin hexoside | ||
| 575(−), adduct | succinate | |||||
| 24 | 45.5 | 533(+) 283 (−), frag. | 260, 325sh | Biochanin A hexoside malonate | ||
| 25 | 45.8 | 281(−) | Pseudobaptigenin | |||
| 26 | 46.6 | 267(−) | 252 | 301 | Formononetin | |
| 27 | 49.7 | 547(+) | 260, 328sh | Biochanin A | ||
| 591(−), adduct | conjugate | |||||
| 28 | 52.6 | 283(−) | 268 | 260, 326sh | Biochanin A |
MS retention time (t.
main leaf PPO substrates,
potential leaf PPO substrates,
flavonoids synthesized in chloroplasts,
potential PPO substrates monophenol substrate detected in chloroplasts. Values in bold indicate the base peak that are fragmented in MS.
Figure 6Chloroplastic phenolics in low leaf PPO mutant and wild-type plants grown in a two phase cross over design. Chloroplastic phenolics (A) coumaroyl hexoside, (B) coumaroyl malate, and (C) caffeoyl malate (phaselic acid) detected in first phase (cross hatching) and second phase (stippled) of two phase cross over design. MUT, Mutant; WT, wild-type; error bars ± SEM (n = 3).
Figure 7Proposed pathway for conversion of coumaroyl hexoside to coumaroyl malate catalyzed by hydroxycinnamoylglucose:malate hydroxycinnamoyltransferase (HMT) (Lehfeldt et al., .